SEC Form D filing

Atommap Corp, 2026-03-20

An SEC Form D private-offering notice from New York, NY, a $59,630,328 filer-stated offering target in Biotech. Filed 2026-03-20. The source filing is one click away. For companies that filed this week, open the live feed.

What this filing says

Atommap Corp site↗ Verified via SEC Form D

Computational drug discovery company, rebranded from Atommap to Fathom Therapeutics, using physics based and AI augmented molecular simulation to design therapeutic small molecules.

Filed 2026-03-20Filed to raise $59,630,328First money in 2026-03-06Raised so far $31,130,335HQ (as filed) New York, NYSector Biotech web-verified against the company’s own siteStage (inferred) GrowthCall status Call-ready
Source linked the Form D on EDGAR↗Website verified fathomtx.com↗Named in the filing 2 executives & directors
Open this row on the live feed →More new filings in New York →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source